Evidence map›Paper›PMID 35041752›Full record

ArticleEndocrine reviews2022

A Clinical Update on Gestational Diabetes Mellitus.

Arianne Sweeting, Jencia Wong, Helen R Murphy, Glynis P Ross

2 registry-linked trialsOpen access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Endocrine reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 481 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
481citing papers in PubMed, 11 pooled it
140.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06355154 narecruitingnot on this mapstarted 2024, after this paper: background citation

Effects of Moderate Carbohydrate Consumption on Metabolic and Obstetric Outcomes in Pregnant Women With Insulin-treated Diabetes- A Randomized Controlled Trial

TypeinterventionalSponsorHadassah Medical OrganizationRan2024 to 2028Enrolled120ConditionsDiabetes in PregnancyArmsNutritional intervention
NCT07345143 naenrolling by invitationnot on this mapstarted 2024, after this paper: background citation

Artificial Intelligence in Education and Monitoring Women With Gestational Diabetes

TypeinterventionalSponsorJOSE FERNANDO VILELA-MARTINRan2024 to 2027Enrolled100ConditionsGestational Diabetes, Macrosomia, FetalArmsmonitoring model for women with gestacional diabetes using pharmacological therapy
3 · Its place in the literature

Who cites it

481 citing papers in PubMed, 11 syntheses or guidelines pooled it, 812 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Review
  16. Article
  17. Review
  18. Observational
  19. Article
  20. Article

421 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Arianne SweetingDepartment of Endocrinology, Royal Prince Alfred Hospital, Sydney, Australia.ORCID 0000-0001-6843-6247
Jencia WongDepartment of Endocrinology, Royal Prince Alfred Hospital, Sydney, Australia.
Helen R MurphyDiabetes in Pregnancy Team, Cambridge University Hospitals, Cambridge, UK.
Glynis P RossDepartment of Endocrinology, Royal Prince Alfred Hospital, Sydney, Australia.ORCID 0000-0002-9962-052X
The University of Sydney · AUUniversity of East Anglia · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gestational diabetes mellitus (GDM) traditionally refers to abnormal glucose tolerance with onset or first recognition during pregnancy. GDM has long been associated with obstetric and neonatal complications primarily relating to higher infant birthweight and is increasingly recognized as a risk factor for future maternal and offspring cardiometabolic disease. The prevalence of GDM continues to rise internationally due to epidemiological factors including the increase in background rates of obesity in women of reproductive age and rising maternal age and the implementation of the revised International Association of the Diabetes and Pregnancy Study Groups' criteria and diagnostic procedures for GDM. The current lack of international consensus for the diagnosis of GDM reflects its complex historical evolution and pragmatic antenatal resource considerations given GDM is now 1 of the most common complications of pregnancy. Regardless, the contemporary clinical approach to GDM should be informed not only by its short-term complications but also by its longer term prognosis. Recent data demonstrate the effect of early in utero exposure to maternal hyperglycemia, with evidence for fetal overgrowth present prior to the traditional diagnosis of GDM from 24 weeks' gestation, as well as the durable adverse impact of maternal hyperglycemia on child and adolescent metabolism. The major contribution of GDM to the global epidemic of intergenerational cardiometabolic disease highlights the importance of identifying GDM as an early risk factor for type 2 diabetes and cardiovascular disease, broadening the prevailing clinical approach to address longer term maternal and offspring complications following a diagnosis of GDM.

Indexed as

Cardiovascular DiseasesDiabetes, GestationalDiabetes Mellitus, Type 2HyperglycemiaAdolescentChildFemaleFetal MacrosomiaGlucoseHumansInfant, NewbornPregnancyGlucosebiomarkersCOVIDdiabetes preventiondiagnosisgeneticsgestational diabetes mellitusmanagementoutcomespathophysiologyprecision medicine

Identifiers

PMID35041752
PMCPMC9512153
OpenAlexW4205324281

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.